Skip to main content

Table 1 Comparison between different laboratory parameters before and 12 weeks after EOT

From: Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs

Variables

Before treatment

12 weeks after treatment

Test of significance

P-value

Hemoglobin (g/dL)

Mean ± SD

13.39 ± 1.49

13.28 ± 1.50

t= 1.713

0.095

Range

10.80–16.40

10.70–16.40

TLC (×103/mL)

Mean ± SD

5.46 ± 1.46

5.52 ± 1.51

t=3.028*

0.004*

Range

2.50–8.80

2.50–9.0

Platelets

(×103/mL)

Mean ± SD

254.9 ± 91.45

252.1 ± 87.51

t= 1.657

0.106

Range

84.0–426.0

103.0–420.0

AST

(IU/L)

Mean ± SD

37.25 ± 13.95

33.10 ± 13.74

Z= 5.102*

<0.001*

Range

22.0–70.0

20.0–65.0

ALT

(IU/L)

Mean ± SD

38.33 ± 10.52

34.30 ± 9.99

t= 5.801*

<0.001*

Range

25.0–65.0

20.0–58.0

Albumin (g/dL)

Mean ± SD

3.88 ± 0.35

4.05 ± 0.33

t= 9.837*

<0.001*

Range

3.0–4.60

3.30–4.70

Total bilirubin (mg/dL)

Mean ± SD

0.85 ± 0.44

0.73 ± 0.32

Z= 5.520*

<0.001*

Range

0.30–2.0

0.28–1.80

INR

Mean ± SD

1.12 ± 0.18

0.97 ± 0.15

t= 6.376*

<0.001*

Range

0.89–1.60

0.79–1.50

  1. t paired t-test, Z Wilcoxon signed-ranks test, *significant